<DOC>
	<DOCNO>NCT03077516</DOCNO>
	<brief_summary>The purpose study evaluate clinical patient-reported outcome 10 year follow surgery cohort Mobi-C subject treat IDE/Post Approval study</brief_summary>
	<brief_title>Post-Market , Long-Term Follow Up Mobi-C® Cervical Disc One Two Level Treatment Cervical Disc Disease</brief_title>
	<detailed_description>This prospective , multi-center , consecutive cohort study . Subjects invited participate study complete Mobi-C IDE study ( G050212 ) . In study , five hundred seventy-five subject randomize either Mobi-C prosthesis control treatment - conventional anterior cervical discectomy fusion ( ACDF ) anterior cervical plating . The study randomize 2 1 ratio ( two Mobi-C subject every one subject receive ACDF anterior cervical plate ) . The subject retention rate Mobi-C subject 80.1 % ( 1 level ) -84.4 % ( 2 level ) 7 year . As non-inferiority ( 1-level ) superiority ( 2-level ) well establish 7 year , design study focus long-term outcome cohort Mobi-C arm study evaluate durability outcomes 10 year . Study sit invite participate enrol least 10 subject , also high retention rate 7 year ( ≥70 % ) . All subject site contact participate additional 10 year follow visit . It estimate 250 subject enrol 9-12 study site .</detailed_description>
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>1 . Treatment MobiC one two level LDR001 Pivotal Study ( IDE G050212 ) ; 2 . Written inform consent provide subject subject 's legally authorize representative 1 . Documented withdrawal consent prior MobiC study ; 2 . Documented noncompliance ( include unwillingness return site followup visit ) 3 . Reported pregnancy time enrollment , plan become pregnant prior completing study XRays</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>